Go to Client Portal

Why Regional Reimbursement Strategies Could Be Right For Medtech

Originally published in Medical Device & Outsourcing, a MassDevice Resource The medtech space is facing increasing challenges, particularly in the reimbursement space. Although the process is difficult, device makers may find that regional reimbursement strategies better suit their immediate needs to get products to market, according to experts at NAMSA. Let’s start with the challenges. … Continued

Focus on Japan Series: Part II – Understanding the Designated Marketing Authorization (D-MAH) Status for Foreign Device Manufacturers

Over the last few weeks, NAMSA’s Japanese medical device development experts have been discussing a variety of regulatory topics related to Japan’s unique product development and manufacturing landscape. This series is intended to provide helpful information and best practices that lead to successful device operations in this quickly growing device marketplace. Introduction to D-MAH When … Continued